Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Vitolo

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Blood|November 27, 2025
Better together: epcoritamab boosts R2 in FLUmberto Vitolo, Francesca Bonello
Future Oncology (London, England)|February 11, 2017
Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphomaGrzegorz S Nowakowski, Umberto Vitolo
Hematological Oncology|June 19, 2013
XVI. CNS prophylaxis in aggressive lymphomas: for whom and howGiulia Benevolo, Annalisa Chiappella, Umberto Vitolo
Expert Review of Hematology|October 31, 2013
The risk of CNS involvement in aggressive lymphomas in the rituximab eraGiulia Benevolo, Annalisa Chiappella, Umberto Vitolo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
Extranodal lymphomasAnnalisa Chiappella, Giulia Benevolo, Umberto Vitolo
The New England Journal of Medicine|February 7, 2014
The role of myeloablation for lymphomaNorbert Schmitz, Marita Ziepert, Umberto Vitolo, et al.
Hematology/Oncology Clinics of North America|November 28, 2016
State-of-the-art Therapy for Advanced-stage Diffuse Large B-cell LymphomaAnnalisa Chiappella, Alessia Castellino, Umberto Vitolo
British Journal of Haematology|November 18, 2020
Partial responses to ibrutinib in Waldenström macroglobulinaemia - good enough?Umberto Vitolo, Mattia Novo, Elisa Santambrogio
Expert Review of Hematology|June 9, 2017
Current options to manage Waldenström's macroglobulinemiaGiulia Benevolo, Maura Nicolosi, Elisa Santambrogio, et al.
The Lancet. Oncology|October 4, 2017
Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma - Authors' replyAnnalisa Chiappella, Maurizio Martelli, Andrea Evangelista, et al.
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Blood|November 27, 2025
Better together: epcoritamab boosts R2 in FLUmberto Vitolo, Francesca Bonello
Future Oncology (London, England)|February 11, 2017
Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphomaGrzegorz S Nowakowski, Umberto Vitolo
Hematological Oncology|June 19, 2013
XVI. CNS prophylaxis in aggressive lymphomas: for whom and howGiulia Benevolo, Annalisa Chiappella, Umberto Vitolo
Expert Review of Hematology|October 31, 2013
The risk of CNS involvement in aggressive lymphomas in the rituximab eraGiulia Benevolo, Annalisa Chiappella, Umberto Vitolo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
Extranodal lymphomasAnnalisa Chiappella, Giulia Benevolo, Umberto Vitolo
The New England Journal of Medicine|February 7, 2014
The role of myeloablation for lymphomaNorbert Schmitz, Marita Ziepert, Umberto Vitolo, et al.
Hematology/Oncology Clinics of North America|November 28, 2016
State-of-the-art Therapy for Advanced-stage Diffuse Large B-cell LymphomaAnnalisa Chiappella, Alessia Castellino, Umberto Vitolo
British Journal of Haematology|November 18, 2020
Partial responses to ibrutinib in Waldenström macroglobulinaemia - good enough?Umberto Vitolo, Mattia Novo, Elisa Santambrogio
Expert Review of Hematology|June 9, 2017
Current options to manage Waldenström's macroglobulinemiaGiulia Benevolo, Maura Nicolosi, Elisa Santambrogio, et al.
The Lancet. Oncology|October 4, 2017
Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma - Authors' replyAnnalisa Chiappella, Maurizio Martelli, Andrea Evangelista, et al.
Pageof 22